<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:mobile="http://www.google.com/schemas/sitemap-mobile/1.0" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1">
<url><loc>https://polesocietes.com/actualites/levee-de-fonds/tsuga-levee-35-millions-observabilite-ia</loc><image:image><image:loc>https://cms.polesocietes.com/assets/6c487a9b-4bb6-419d-baf7-cc9f90e947e0</image:loc></image:image><news:news><news:publication><news:name>PoleSocietes&#46;com</news:name><news:language>fr-fr</news:language></news:publication><news:publication_date>2026-07-02T08:45:03.000+00:00</news:publication_date><news:title>Tsuga l&#232;ve 35 M&#36; &#58; l&#39;observabilit&#233; &#224; l&#39;&#232;re de l&#39;IA</news:title></news:news></url>
<url><loc>https://polesocietes.com/actualites/levee-de-fonds/bionyra-pharma-levee-fonds-165-millions</loc><image:image><image:loc>https://cms.polesocietes.com/assets/9f6b56e3-117a-43c7-9699-7e27b611057c</image:loc></image:image><news:news><news:publication><news:name>PoleSocietes&#46;com</news:name><news:language>fr-fr</news:language></news:publication><news:publication_date>2026-06-30T10:38:54.000+00:00</news:publication_date><news:title>Bionyra Pharma &#58; 165M&#36; pour r&#233;volutionner l&#39;immunologie</news:title></news:news></url>
</urlset>